158 related articles for article (PubMed ID: 3579056)
1. [Effectiveness and tolerance of the treatment of infantile bronchial asthma with soluble and delayed-action theophylline].
Navarro M; Durán JA; Delgado JA; Serrano JS; González Hachero J
An Esp Pediatr; 1987 Mar; 26(3):171-7. PubMed ID: 3579056
[TBL] [Abstract][Full Text] [Related]
2. Theophylline administration in children with asthma: optimal pulmonary function and possible tolerance to chronic administration.
Katz RM; Rachelefsky GS; Siegel SC; Mickey R
Ann Allergy; 1983 Jan; 50(1):23-6. PubMed ID: 6849515
[TBL] [Abstract][Full Text] [Related]
3. Reduction in the oral doses of theophylline in asthmatic children during concomitant treatment with ketotifen.
Solé D; Mallozi MC; Toledo EC; Passos Soares FJ; Naspitz CK
Allergol Immunopathol (Madr); 1992; 20(2):57-60. PubMed ID: 1442450
[TBL] [Abstract][Full Text] [Related]
4. [Sustained-release theophylline: study in a child population].
Díaz Fernández M; Gracía Hidalgo A; Mateo Cañas G; López Elorze F
An Esp Pediatr; 1986 Jan; 24(1):7-13. PubMed ID: 3963648
[TBL] [Abstract][Full Text] [Related]
5. [Continuous treatment of asthma in children with theophylline retard].
de Blic J; Scheinmann P; Benoist MR; Ruff F; Paupe J
Arch Fr Pediatr; 1983 Feb; 40(2):123-7. PubMed ID: 6870478
[TBL] [Abstract][Full Text] [Related]
6. [Sustained-action oral theophylline in the asthmatic child. Clinical, pharmacokinetic and respiratory function studies].
Baculard A; Morgant G; Gaultier C; Boule M; Tournier G
Rev Fr Mal Respir; 1983; 11(6):833-46. PubMed ID: 6669796
[TBL] [Abstract][Full Text] [Related]
7. [Clinical effectiveness of a new preparation of sustained-release theophylline].
Corrias A; Pelosi U; Corona GB; Burrai P; Corda R
Pediatr Med Chir; 1989; 11(5):537-9. PubMed ID: 2631061
[TBL] [Abstract][Full Text] [Related]
8. [Aminophylline-retard preparation in the treatment of patients with bronchial asthma].
Branica S; Vrabec B; Francetić I; Bakran I
Lijec Vjesn; 1989; 111(9-10):341-3. PubMed ID: 2633012
[TBL] [Abstract][Full Text] [Related]
9. Comparison of a short course of prednisolone with sustained-release theophylline in the control of nocturnal asthma.
Chhabra SK
Indian J Chest Dis Allied Sci; 1995; 37(1):7-14. PubMed ID: 16892732
[TBL] [Abstract][Full Text] [Related]
10. [Clinical study on the efficacy of a sustained-release theophylline-based preparation in infants with chronic asthma].
Bertolani P; Bernini GC; Amarri S; Accorsi P
Pediatr Med Chir; 1985; 7(5):765-9. PubMed ID: 3837245
[TBL] [Abstract][Full Text] [Related]
11. [Therapy of obstructive respiratory tract diseases with pure theophylline retard].
Arens PJ
Med Klin Prax; 1982 Aug; 77(18):48-53, 67. PubMed ID: 6752679
[TBL] [Abstract][Full Text] [Related]
12. Serum theophylline levels in asthmatic children after oral administration of a slow-release aminophylline preparation (Phyllocontin Continus tablets).
McKenzie S; Baillie E
J Int Med Res; 1979; 7 Suppl 1():22-7. PubMed ID: 437305
[TBL] [Abstract][Full Text] [Related]
13. Pharmacokinetics and pharmacodynamics of three sustained-release theophylline preparations (350 mg Theograd, 350 mg Theolair Retard and 300 mg Theodur) in steady state in healthy volunteers and asthmatics--Part I: Theophylline plasma levels.
van der Vet AP; Drost RH; Kreukniet J; Maes RA
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):423-9. PubMed ID: 6490224
[TBL] [Abstract][Full Text] [Related]
14. [Pulmonary volume and flows in asthmatic children in therapy with prompt and delayed-action theophylline: preliminary report].
Fiocchi A; Berardinelli P; Di Donna C; Arensi D; Riva E
Pediatr Med Chir; 1984; 6(5):641-4. PubMed ID: 6535125
[TBL] [Abstract][Full Text] [Related]
15. [Effect of low dose of inhaled corticosteroid combined with small dose of oral theophylline on treatment of bronchial asthma].
Li J; Mo H; Huang H
Zhonghua Jie He He Hu Xi Za Zhi; 2000 Jun; 23(6):336-9. PubMed ID: 11778513
[TBL] [Abstract][Full Text] [Related]
16. Serum drug fluctuations after administration of two sustained-release oral theophylline preparations in asthmatic children.
Logvinoff MM; Weinstein DB; Watts MT; Seifert B
Clin Ther; 1986; 8(2):175-80. PubMed ID: 3698064
[TBL] [Abstract][Full Text] [Related]
17. [Monitoring of three delayed-release preparations of theophylline in the plasma of children: pharmacokinetic parameters and therapeutic significance].
Domínguez Granados R; Pita Calandre E; Girón Caro F; Gómez Rubio M; Molina Font JA
An Esp Pediatr; 1987 Nov; 27(5):357-61. PubMed ID: 3439657
[TBL] [Abstract][Full Text] [Related]
18. NTP Toxicology and Carcinogenesis Studies of Theophylline (CAS No. 58-55-9) in F344/N Rats and B6C3F1 Mice (Feed and Gavage Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1998 Aug; 473():1-326. PubMed ID: 12571677
[TBL] [Abstract][Full Text] [Related]
19. The relationship between pharmacodynamics and pharmacokinetics in asthmatic children receiving a sustained-release formulation of theophylline.
Schaefers M; Richter O; Reinhardt D; Becker B
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):406-15. PubMed ID: 6490223
[TBL] [Abstract][Full Text] [Related]
20. A new sustained-release theophylline suspension for asthmatic children: evaluation of serum theophylline concentrations.
Boner AL; Vallone G; Valletta E; Bernocchi D; Plebani M
Int J Clin Pharmacol Res; 1987; 7(5):345-50. PubMed ID: 3667007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
